Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Else Marie Agger

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Plos One|January 12, 2013
The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signalingChristiane Desel, Kerstin Werninghaus, Manuel Ritter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2020
Immunization with <i>Mycobacterium tuberculosis</i>-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in MiceClaus Aagaard, Niels Peter Hell Knudsen, Iben Sohn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogDennis Christensen, Malou Henriksen-Lacey, Arun T Kamath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-GuérinClaire A Swetman Andersen, Ida Rosenkrands, Anja W Olsen, et al.
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
The Journal of Experimental Medicine|January 14, 2009
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activationKerstin Werninghaus, Anna Babiak, Olaf Gross, et al.
Immunity|March 6, 2016
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I InterferonsElizabeth C Carroll, Lei Jin, Andres Mori, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Microbial Cell Factories|November 26, 2014
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccinesWouter S P Jong, Maria H Daleke-Schermerhorn, David Vikström, et al.
Vaccine|December 3, 2014
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in humanJaap T van Dissel, Simone A Joosten, Søren T Hoff, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Plos One|January 12, 2013
The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signalingChristiane Desel, Kerstin Werninghaus, Manuel Ritter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2020
Immunization with <i>Mycobacterium tuberculosis</i>-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in MiceClaus Aagaard, Niels Peter Hell Knudsen, Iben Sohn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogDennis Christensen, Malou Henriksen-Lacey, Arun T Kamath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-GuérinClaire A Swetman Andersen, Ida Rosenkrands, Anja W Olsen, et al.
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
The Journal of Experimental Medicine|January 14, 2009
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activationKerstin Werninghaus, Anna Babiak, Olaf Gross, et al.
Immunity|March 6, 2016
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I InterferonsElizabeth C Carroll, Lei Jin, Andres Mori, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Microbial Cell Factories|November 26, 2014
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccinesWouter S P Jong, Maria H Daleke-Schermerhorn, David Vikström, et al.
Vaccine|December 3, 2014
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in humanJaap T van Dissel, Simone A Joosten, Søren T Hoff, et al.
Pageof 9